Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-02-24 @ 8:25 AM
Study NCT ID:
NCT01464905
Status:
UNKNOWN
Last Update Posted:
2013-09-23
First Post:
2011-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Sponsor:
Nuron Biotech Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10
Start Date Type:
None
Primary Completion Date:
2013-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2014-12
Completion Date Type:
ESTIMATED
First Submit Date:
2011-10-31
First Submit QC Date:
None
Study First Post Date:
2011-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-20
Last Update Post Date:
2013-09-23
Last Update Post Date Type:
ESTIMATED